Mirum Pharmaceuticals Inc (MIRM)’s Day in Review: Closing at 48.39, Down by -4.91

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

After finishing at $50.89 in the prior trading day, Mirum Pharmaceuticals Inc (NASDAQ: MIRM) closed at $48.39, down -4.91%. In other words, the price has decreased by -$4.91 from its previous closing price. On the day, 0.74 million shares were traded. MIRM stock price reached its highest trading level at $50.71 during the session, while it also had its lowest trading level at $48.235.

Ratios:

Our goal is to gain a better understanding of MIRM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.04 and its Current Ratio is at 3.22. In the meantime, Its Debt-to-Equity ratio is 1.36 whereas as Long-Term Debt/Eq ratio is at 1.35.

On April 17, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $48.

H.C. Wainwright reiterated its Buy rating for the stock on December 18, 2023, while the target price for the stock was revised from $60 to $58.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 11 ’25 when Fairey William sold 3,203 shares for $48.42 per share. The transaction valued at 155,091 led to the insider holds 2,500 shares of the business.

WILLIAM C FAIREY bought 3,203 shares of MIRM for $155,091 on Jun 11 ’25. On Jun 02 ’25, another insider, Ramasastry Saira, who serves as the Director of the company, sold 5,703 shares for $46.20 each. As a result, the insider received 263,492 and left with 0 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MIRM now has a Market Capitalization of 2396984064 and an Enterprise Value of 2560303360. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.32 while its Price-to-Book (P/B) ratio in mrq is 10.26. Its current Enterprise Value per Revenue stands at 6.751 whereas that against EBITDA is -48.95.

Stock Price History:

The Beta on a monthly basis for MIRM is 0.97, which has changed by 0.4282763 over the last 52 weeks, in comparison to a change of 0.11937654 over the same period for the S&P500. Over the past 52 weeks, MIRM has reached a high of $54.23, while it has fallen to a 52-week low of $33.45. The 50-Day Moving Average of the stock is 6.22%, while the 200-Day Moving Average is calculated to be 9.77%.

Shares Statistics:

The stock has traded on average 434.14K shares per day over the past 3-months and 492540 shares per day over the last 10 days, according to various share statistics. A total of 49.45M shares are outstanding, with a floating share count of 40.03M. Insiders hold about 19.18% of the company’s shares, while institutions hold 93.48% stake in the company. Shares short for MIRM as of 1749772800 were 6218308 with a Short Ratio of 14.32, compared to 1747267200 on 6287171. Therefore, it implies a Short% of Shares Outstanding of 6218308 and a Short% of Float of 12.550001.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.